申请人:Mitsubishi Tanabe Pharma Corporation
公开号:EP2896613A1
公开(公告)日:2015-07-22
The present invention provides novel sulfonamide compounds having TRPM8 antagonistic activity which are useful as medicaments. Specifically, the present invention provides a sulfonamide compound of the formula (I):
wherein Ring A is the following formula (i), (ii), or (ix):
R4 is optionally substituted alkyl,
X1 and X2 are each independently tetrazolyl, tetrazolinonyl, optionally substituted triazolyl, triazolinonyl, oxadiazolonyl, optionally substituted alkanoylaminomethyl, or optionally substituted alkylsulfonylaminomethyl, or
R4 and X2 combine with each other at their terminals together with the adjacent benzene to form indazolinonyl or benzoisoxazolonyl, and
the other symbols are the same as described in the specification,
or a pharmaceutically acceptable salt thereof.
本发明提供了具有 TRPM8 拮抗活性的新型磺酰胺化合物,可用作药物。具体而言,本发明提供了一种式(I)的磺酰胺化合物:
其中环 A 为下式(i)、(ii)或(ix):
R4 是任选取代的烷基、
X1和X2各自独立地为四唑基、四唑啉基、任选取代的三唑基、三唑啉基、噁二唑啉基、任选取代的烷酰氨基甲基或任选取代的烷磺酰氨基甲基,或
R4 和 X2 在其末端与相邻的苯相互结合形成吲唑啉基或苯并异噁唑啉基,以及
其他符号与说明书中描述的相同、
或其药学上可接受的盐。